Global Streamlining of Marketing Authorisation
Short Course

Drug regulation overseas the ongoing assessment of product safety, efficacy, and quality and promotes the development and availability of new and better products to protect public health. Globalisation of drug development challenges regulators and the regulated industry around the world. Harmonisation of requirements, mutual recognition of evaluations and other means of work sharing are strategies for keeping pace with the progress of globalisation.

In this context, a new strategic regulatory approach and greater harmonisation, coordination and alignment of regulatory rules among nations is evolving.

Join us to learn how collaboration of pharmaceutical industries and health authorities foster global streamlining of marketing authorisation.

The course language is English.

  • Dr. Annette Mollet, Studiengangleitung
  • Prof. Dr. Thomas Szucs, Studiengangkommission

The ECPM teaching faculty consists of about 130 international experts in regulatory sciences, medical product discovery and development, product evaluation and business practices.

Institute of Pharmaceutical Medicine
University of Basel
Klingelbergstrasse 61
CH-4056 Basel

Tel. +41 61 207 19 50

CHF 680
CHF 580 for ECPM Alumni and SwAP / SGPM members
CHF 210 for employees of universities and other nonprofit

The fee includes meeting materials (electronic), lunch, breaks and coffee. After registration you will receive an in voice. For short notice registration, please provide a copy of the money transfer at the registration desk.

Refund of fee will be given if cancellation is received in writing before the deadline for registration, after this date no refund can be given.

ECPM, European Center of Pharmaceutical Medicine, part of the Medical faculty of the University of Basel together with other universities and different partners

Dates to be confirmed.

Fields marked with * are mandatory


University Hospital Basel Hörsaal Pathologie, Schönbeinstrasse 40, 4051 Basel

to top